The Foreign Investment Promotion Board (FIPB) has deferred a decision on FDI proposals of Vodafone Mobile Services, the finance ministry said in a statement.

The board approved six FDI proposals involving inflows of Rs 84.69 crore and rejected five proposals.

Gland Pharma Limited, a brownfield pharmaceutical Indian company, is seeking approval for its initial acquisition of up to 86.08 per cent by Shanghai Fosun Pharmaceutical (Group) Company Limited, a public listed company incorporated in China, the ministry said in a release.

"Subsequently, Fosun also has the contractual right to acquire 100 per cent shares of Gland Pharma from other shareholders of the company in one or more tranches," it added.

The proposal of Gland Pharma has been recommended for approval of Cabinet Committee on Economic Affairs (CCEA), the ministry said. The proposal entails FDI worth Rs 4,315 crore.

The proposals approved by the FIPB include a Rs 65-crore PMC Group International's proposal and Crown Cement Manufacturing India Pvt Ltd's for Rs 15.51 crore investment.

The release further said Vodafone Mobile Services Ltd,a 100 per cent foreign owned Indian company has sought post- facto approval for the scheme of amalgamation among Vodafone Mobile Services Limited, Vodafone Digilink Limited, Vodafone South Limited, Vodafone East Limited and Vodafone Cellular Limited.

However, the Board headed by Economic Affairs Secretary Shaktikanta Das deferred decision on the application.

Subscribe to our Newsletters

Earlier people used to visit a pharmacy or a medical store only when they used to be sick but today there is an evolving trend. Now people have suddenly realized that there is a huge potential in being healthy.